Products & services
At Samabriva, we specialize in producing high-value molecules for biopharmaceuticals and APIs. We provide research and contract development and manufacturing services (CDMO) or technology licensing to our pharmaceutical and biotech partners.
Our single-use bioreactor platform can produce several hundred liters of product in our facility in Liège, Belgium. The system is highly adaptable and enables continuous and reproducible production of various molecules, all year-round, and in any location
Download the brochure to explore
Samabriva’s technology and how it can meet your needs.
Our commercial offer:
Ready to grow with us?
Talk to us today to find out how our innovative bioproduction platform can help meet your needs.
Research Services:
We provide research and process development services for botanical ingredients production in our R&D facility in Amiens, France.
Our research services specialise in:
- careful selection of the appropriate plant species that express the target molecule
- genetic modification, if required, to increase the productivity of the desired natural compounds
- generation of the hairy roots
- identification and isolation of high-yielding clones
- Design of Experiments (DoE) methodology for clone amplification and culture optimization to maximize target molecule production
Samabriva Biomanufacturing – CDMO services:
Our new, 1,400 m² biomanufacturing facility in Liege, Belgium, is in the heart of Europe’s biotech valley. It is designed to provide industrial-scale production of high-value natural molecules for the manufacture of pharmaceutical products.
Our CDMO services specialise in:
- pilot-scale process development and optimization
- creation of Research, Master, and Working « Root » Banks
- scale-up to large-scale proprietary bioreactors
- commercial scale production of GMP quality APIs (up to 70 m3/month)
The facility is designed to expand to provide advanced manufacturing that meets the needs of our commercial customers globally.
